IP Library Granted Patent US 7,264,931
Granted Patent B2
US 7,264,931 · App. 10/344,891 · Granted Sep 4, 2007

Method for sequencing nucleic acid sequences without chain termination

Assignee: Rutgers, the State University of New Jersey
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,264,931
App. No.
10/344,891
Granted
Sep 4, 2007
Kind
B2
Abstract

A method is provided for determining the sequence of a nucleic acid sequence via incubation of a primer extended product of the nucleic acid sequence in separate pools of semi-random oligonucleotides of 5′ (N) n A3′, 5′ (N) n G3′, and 5′ (N) n T3′, wherein N is A, C, G or T and n is selected so that the oligonucleotides will optimally anneal to all complementary sequences.

Claims (9)

1. A method for sequencing a nucleic acid sequence comprising:

(a) linearly amplifying the nucleic acid sequence using a first primer which is complementary to a known portion of the nucleic acid sequence to produce a first primer extended product;

(b) incubating the first primer extended product with dNTPs, a DNA polymerase, and separate pools of semi-random oligonucleotide primers consisting of 5′ (N) n A3′, 5′ (N) n C3′, 5′ (N) n G3′, and 5′ (N) n T3′, wherein N is A, C, G or T and n is selected so that the oligonucleotides will optimally anneal to all complementary sequences, thereby generating four pools of primer extended products;

(c) incubating each of the four pools of primer extended products with a second detectably labeled primer which is complementary to a known portion of the nucleic acid sequence to produce detectably labeled extension products via linear amplification; and

(d) separating the detectably labeled extension products by size; and

(e) reading the sequence of the detectably labeled extension products via an automated sequencing machine.

2. The method of claim 1 wherein the nucleic acid sequence is genomic DNA.

3. The method of claim 1 wherein the nucleic acid is a DNA selected from the group consisting of oligonucleotide primers, PCR products, viral DNA and plasmid DNA.

4. The method of claim 1 wherein the nucleic acid sequence is cDNA derived from RNA by reverse transcriptase.

Assignments (2)
CONFIRMATORY LICENSE Recorded Feb 5, 2021
From: RUTGERS, THE STATE UNIV OF NJ
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 055157/0128 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2007
From: GABRIEL, ABRAHAM; KOBAYASHI, YOSHIFUMI
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 019619/0937 →
Continuity (2)
Provisional Application 6023039000 · Sep 6, 2000
Related Publication 20040014076A1 · Jan 22, 2004